IDEAYA Biosciences Reports Q2 2026 Financial Results

What Happened
IDEAYA Biosciences, Inc. announced its financial results for the second quarter ended June 30, 2026 and filed a Current Report on Form 8-K on August 4, 2026 to disclose the results. The company furnished the full press release announcing the quarterly results as Exhibit 99.1 to the Form 8-K.

Key Details

• Form 8-K filed: August 4, 2026 (Item 2.02 — Results of Operations and Financial Condition).
• Quarter covered: Quarter ended June 30, 2026 (Q2 2026).
• Exhibit included: Press Release dated August 4, 2026 (Exhibit 99.1).
• Interactive XBRL cover page file provided (Exhibit 104).

Why It Matters
Quarterly results provide updated information on IDEAYA’s recent performance—revenue, profitability, cash position, and any operational or program updates—which can influence investor decisions and the stock price. Retail investors should review the Exhibit 99.1 press release and accompanying SEC filings for the specific financial figures and management commentary before making investment decisions.